Xermelo: payments to doctors
Payments that named Xermelo as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $936K
- Providers
- 3,985
- Transactions
- 7,905
- Average per transaction
- $118
The per-transaction average — $118 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,985 providers the average total is $235, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Tersera Therapeutics LLC | $576,287 | 61.6% |
| Lexicon Pharmaceuticals, Inc. | $359,642 | 38.4% |